Senior insider sale
Chief Commercial Officer at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$633.4K
1.33K shares
What this filing means
HUNTSMAN CAROLE plans to sell 1.33K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $633.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/6/2026ACC: 0001628280-26-015740
Officer· Chief Commercial Officer
Since Mar 2026
1.33K
Shares to sell
$633.4K
Approx. market value
419.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
3/5/2026
419.00Total acquired419.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/5/2026 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 419.00 | — |
| Total | 419.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
570.00
Market value
$281.9K
1/26/2026
—Completed
Units to sell
340.00
Market value
$167.4K
1/26/2026
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
419.00
Market value
$184.1K
3/6/2026
Total
Units
1.33K
Value
$633.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/26/2026 | 570.00 | $281.9K | — | Completed |
1/26/2026 | 340.00 | $167.4K | — | Completed |
| Planned — Approximate Date | ||||
3/6/2026 | 419.00 | $184.1K | Nasdaq Stock Market | Planned |
| Total | 1.33K | $633.4K | ||